Research programme: opioid mu receptor agonists - Mebias Disovery
Alternative Names: MEB-1051Latest Information Update: 28 Sep 2020
At a glance
- Originator MEBIAS Discovery
- Class Analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 08 Sep 2020 Opioid mu receptor agonists - Mebias Disovery is available for licensing as of 08 Sep 2020. https://mebiasdiscovery.com/opportunities/
- 08 Sep 2020 Preclinical trials in Pain in USA (unspecified route) prior to September 2020 (Mebias pipeline, September 2020)